HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan.

Source:http://linkedlifedata.com/resource/pubmed/id/18380625

Download in:

View as

General Info

PMID
18380625